TERN250516P6000
- 0.00
- 0.000.00%
Terns Pharmaceuticals Newsroom
Mizuho Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Maintains Target Price $14
JMP Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Maintains Target Price $20
Terns Pharma Analyst Ratings
Mizuho Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Maintains Target Price $14
TD Cowen Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating
Oppenheimer Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Maintains Target Price $20
William Blair Maintains Terns Pharmaceuticals(TERN.US) With Hold Rating
JMP Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Maintains Target Price $20
William Blair Reaffirms Their Hold Rating on Terns Pharmaceuticals (TERN)
William Blair Maintains Terns Pharmaceuticals(TERN.US) With Hold Rating
William Blair Maintains Terns Pharmaceuticals(TERN.US) With Hold Rating
Terns Pharma Analyst Ratings
William Blair Initiates Terns Pharmaceuticals(TERN.US) With Hold Rating
JMP Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Maintains Target Price $20
Mizuho Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Maintains Target Price $14
Mizuho Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Maintains Target Price $14
Oppenheimer Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Maintains Target Price $20
JMP Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Maintains Target Price $20
Mizuho Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Announces Target Price $14
Mizuho Securities Reaffirms Their Buy Rating on Terns Pharmaceuticals (TERN)